FDA Inspection
Hevert Arzneimittel GmbH & Co. KGHevert Arzneimittel GmbH & Co. KG – FDA Inspection, Dec 6, 2022
Record Details
This FDA Inspection record concerns Hevert Arzneimittel GmbH & Co. KG, with an inspection on December 6, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 6, 2022
- Product Type
- Drugs
View Company Profile
ID · f0d166bb-ce23-485f-aff9-b98a505653de
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1276837
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Hevert Arzneimittel GmbH & Co. KG
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 12, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 29, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Hevert Arzneimittel GmbH & Co. KG
- FDA Inspection 1127151 - 2020-03-12
- FDA Inspection 1026975 - 2017-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.